search results for

refine results

sort by


result type


Press Releases

Biotech's $20 billion Merger Monday sparks hope for more deals

Three weeks into 2018, deal activity in the biotech sector is already almost halfway to what it was in 2017, at least in terms of size.


Davos flashback: 7 inspiring life advice quotes from major leaders

“You can always go faster than you think you can,” said Meg Whitman, outgoing Hewlett-Packard Enterprise CEO, at Davos in 2016.


Health care experts urge workers to stay home if they are sick with flu

CNBC's Meg Tirrell reports employees that go to work sick contribute to the further spread of influenza and lost productivity.


Sanofi nears $11.4 billion deal for Bioverativ: source

French drugmaker Sanofi is close to acquiring biotechnology company Bioverativ for $105 a share.


Flu's terrible this season. But many of us aren't staying home like we should

Flu is especially bad this season, and going into work while we're sick risks spreading flu further.


Flu season ramped up in last weeks of 2017

CNBC's Meg Tirrell breaks down factors from the worst flu season since 2010 and the effectiveness of the current flu shot.


Widespread flu outbreak causing serious complications this year

Some states are reporting a higher number of deaths from flu this year than usual. CNBC's Meg Tirrell takes a look at how the medical community is dealing with the outbreak.


JNJ CEO: DACA important at a personal level

Johnson & Johnson CEO Alex Gorsky, a grandson of immigrants, talked to Meg Tirrell about the importance of the Dream Act to the company, which recently joined the Coalition for the American Dream in support of DACA recipients.


Regeneron CEO talks drug pricing and tax reform

CNBC's Meg Tirrell speaks with Leonard Schleifer, Regeneron CEO, about how the company will benefit from tax cuts, as well as pricing competition among drug companies.


Verily's project baseline: 'Google Maps for health'

CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.